💊
Hycamtin
topotecan
Neoplasias ováricas; neoplasias del cuello uterino; carcinoma de pulmón de células pequeñas
✅ Autorizado
✅
No hay alertas activas
Este medicamento no tiene escasez en curso, cartas de seguridad ni retiradas del mercado.
Para qué se utiliza
Hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate. Topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy. Hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate.
⚠️ Seguridad del paciente
No
📚 Alertas pasadas (2)
Página oficial de la EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/hycamtin